TECH

59.54

6.16% -3.91

Handel nachbörslich: 59.54

Bio Techne Corp (TECH)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit Dividendenhistorie

Schlusskurs vom Vortag:

$63.45

Offen:

$62.82

24-Stunden-Volumen:

2.89M

Relative Volume:

1.42

Marktkapitalisierung:

$9.32B

Einnahmen:

$1.22B

Nettoeinkommen (Verlust:

$77.95M

KGV:

121.71

EPS:

0.4892

Netto-Cashflow:

$224.06M

1W Leistung:

-9.60%

1M Leistung:

-10.55%

6M Leistung:

+12.70%

1J Leistung:

-11.71%

1-Tages-Spanne:

$58.04

$63.45

1-Wochen-Bereich:

$58.04

$67.60

52-Wochen-Spanne:

$46.01

$72.16

Bio Techne Corp Stock (TECH) Company Profile

Firmenname

Bio Techne Corp

Sektor

Healthcare (1112)

Branche

Biotechnology (621)

Telefon

612-379-8854

Adresse

614 MCKINLEY PL N E, MINNEAPOLIS, MN

Mitarbeiter

3,100

Twitter

@biotechne

Nächster Verdiensttermin

2024-10-30

Neueste SEC-Einreichungen

TECH's Discussions on Twitter

Compare TECH vs VRTX, REGN, ARGX, ALNY, ONC

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
TECH Bio Techne Corp	59.54	9.93B	1.22B	77.95M	224.06M	0.4892
VRTX Vertex Pharmaceuticals Inc	465.02	117.03B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	783.65	82.35B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	833.54	51.64B	3.06B	1.28B	447.35M	19.67
ALNY Alnylam Pharmaceuticals Inc	308.48	42.58B	3.21B	43.57M	221.36M	0.2405
ONC Beone Medicines Ltd Adr	346.42	38.87B	4.98B	69.60M	525.67M	0.5198

Bio Techne Corp Stock (TECH) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-09-03	Hochstufung	RBC Capital Mkts	Sector Perform → Outperform
2025-08-21	Hochstufung	Citigroup	Neutral → Buy
2025-07-22	Fortgesetzt	Stephens	Overweight
2025-07-09	Eingeleitet	TD Cowen	Buy
2025-05-30	Eingeleitet	Wells Fargo	Overweight
2025-04-09	Herabstufung	KeyBanc Capital Markets	Overweight → Sector Weight
2025-03-18	Eingeleitet	Evercore ISI	Outperform
2025-02-19	Herabstufung	Robert W. Baird	Outperform → Neutral
2024-05-22	Herabstufung	Citigroup	Buy → Neutral
2024-02-08	Eingeleitet	Scotiabank	Sector Outperform
2024-02-02	Herabstufung	Stifel	Buy → Hold
2023-12-07	Eingeleitet	UBS	Buy
2023-08-28	Eingeleitet	William Blair	Outperform
2023-01-10	Hochstufung	Wells Fargo	Underweight → Equal Weight
2022-12-14	Eingeleitet	Deutsche Bank	Buy
2022-12-12	Hochstufung	Citigroup	Neutral → Buy
2022-12-07	Eingeleitet	RBC Capital Mkts	Sector Perform
2022-08-25	Eingeleitet	Credit Suisse	Outperform
2022-04-25	Herabstufung	Wells Fargo	Equal Weight → Underweight
2021-09-15	Hochstufung	KeyBanc Capital Markets	Sector Weight → Overweight
2021-03-08	Hochstufung	Stephens	Equal-Weight → Overweight
2021-02-23	Hochstufung	Stifel	Hold → Buy
2021-01-25	Bestätigt	The Benchmark Company	Buy
2020-11-10	Eingeleitet	KeyBanc Capital Markets	Sector Weight
2020-09-30	Eingeleitet	Atlantic Equities	Overweight
2020-07-15	Herabstufung	Stephens	Overweight → Equal-Weight
2020-05-27	Herabstufung	Stifel	Buy → Hold
2020-05-14	Eingeleitet	The Benchmark Company	Buy
2020-01-08	Fortgesetzt	Stephens	Overweight
2020-01-08	Eingeleitet	Wells Fargo	Equal Weight
2020-01-07	Eingeleitet	Citigroup	Neutral
2019-11-15	Eingeleitet	Stifel	Buy
2019-07-02	Hochstufung	Janney	Neutral → Buy
2019-01-14	Hochstufung	Stephens	Equal-Weight → Overweight
2018-10-31	Herabstufung	Craig Hallum	Buy → Hold
2018-10-17	Eingeleitet	Goldman	Neutral
2018-06-15	Eingeleitet	Argus	Buy
2017-07-13	Eingeleitet	Wells Fargo	Market Perform
2017-02-09	Eingeleitet	Citigroup	Buy
2017-01-18	Eingeleitet	Deutsche Bank	Buy
2016-11-10	Fortgesetzt	Leerink Partners	Outperform
2015-01-21	Bestätigt	Robert W. Baird	Outperform
2013-09-20	Hochstufung	Robert W. Baird	Neutral → Outperform

Alle ansehen

Bio Techne Corp Aktie (TECH) Neueste Nachrichten

Feb 11, 2026

(TECH) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily

Feb 11, 2026

5 Insightful Analyst Questions From Bio-Techne's Q4 Earnings Call - Finviz

Feb 11, 2026

There May Be Reason For Hope In Bio-Techne's (NASDAQ:TECH) Disappointing Earnings - Yahoo Finance

Feb 11, 2026

Madison Asset Management LLC Acquires Shares of 744,651 Bio-Techne Corp $TECH - MarketBeat

Feb 11, 2026

Bio-Techne (NASDAQ:TECH) Stock Rating Upgraded by Zacks Research - MarketBeat

Feb 11, 2026

Bio-Techne Corp (NASDAQ:TECH) Passes Key Quality Investing Screen - ChartMill

Feb 11, 2026

Baader Bank Aktiengesellschaft Buys 38,082 Shares of Bio-Techne Corp $TECH - MarketBeat

Feb 11, 2026

Bio-Techne: How Spatial Biology Innovation Is Powering a Strategic Comeback! - Smartkarma

Feb 11, 2026

Feb 10, 2026

Azzad Asset Management Inc. ADV Has $774,000 Stock Holdings in Bio-Techne Corp $TECH - MarketBeat

Feb 10, 2026

Feb 09, 2026

How Flat Sales, Higher EPS, and New Organoid Tools At Bio-Techne (TECH) Have Changed Its Investment Story - Yahoo Finance

Feb 09, 2026

Feb 07, 2026

Bio-Techne stock price target raised to $65 from $60 at Stifel By Investing.com - Investing.com Nigeria

Feb 07, 2026

New York State Common Retirement Fund Sells 465,634 Shares of Bio-Techne Corp $TECH - MarketBeat

Feb 07, 2026

Feb 06, 2026

Bio-Techne stock price target raised to $65 from $60 at Stifel - Investing.com UK

Feb 06, 2026

Wells Fargo & Company Issues Positive Forecast for Bio-Techne (NASDAQ:TECH) Stock Price - MarketBeat

Feb 06, 2026

TECH Stock Update: Wells Fargo Raises Price Target for Bio-Techne | TECH Stock News - GuruFocus

Feb 06, 2026

Beyond the Balance Sheet: What SWOT Reveals About Bio-Techne Cor - GuruFocus

Feb 06, 2026

Feb 05, 2026

Bio-Techne (TECH) Sees Target Price Raised by Stifel | TECH Stoc - GuruFocus

Feb 05, 2026

UBS Maintains Buy Rating on Bio-Techne (TECH) with Raised Price Target | TECH Stock News - GuruFocus

Feb 05, 2026

Citigroup Raises Price Target for Bio-Techne (TECH) to $80.00 | - GuruFocus

Feb 05, 2026

7 Analysts Assess Bio-Techne: What You Need To Know - Benzinga

Feb 05, 2026

Assessing Bio-Techne (TECH) Valuation After Earnings Beat And New Research Product Launches - simplywall.st

Feb 05, 2026

Tech Stock Update: Evercore ISI Group Raises Price Target for TE - GuruFocus

Feb 05, 2026

TD Cowen Maintains Buy Rating on Bio-Techne (TECH) and Raises Pr - GuruFocus

Feb 05, 2026

Leerink Partners Adjusts Price Target on Bio-Techne to $80 From $75, Maintains Outperform Rating - marketscreener.com

Feb 05, 2026

Bio-Techne Corporation (NASDAQ:TECH) Q2 2026 Earnings Call Transcript - Insider Monkey

Feb 05, 2026

Techne Corp. (TECH) Q2 Earnings Report: Results Top Analyst ForecastsNews and Statistics - IndexBox

Feb 05, 2026

TECH Q4 Deep Dive: Margin Expansion and Flat Revenue Amid Mixed End Markets - Finviz

Feb 05, 2026

Feb 04, 2026

Trading Recap: Is Bio Techne Corporation showing insider buying2025 Analyst Calls & Advanced Technical Signal Analysis - baoquankhu1.vn

Feb 04, 2026

Bio-Techne (NASDAQ:TECH) Surprises With Q4 CY2025 Sales - The Globe and Mail

Feb 04, 2026

Bio-Techne Corp Plans Quarterly Dividend of $0.08 (NASDAQ:TECH) - MarketBeat

Feb 04, 2026

Bio-Techne Releases Second Quarter Fiscal 2026 Results - Investing News Network

Feb 04, 2026